Correlation Between Acrivon Therapeutics, and Valneva SE

Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Valneva SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Valneva SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acrivon Therapeutics, Common and Valneva SE ADR, you can compare the effects of market volatilities on Acrivon Therapeutics, and Valneva SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Valneva SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Valneva SE.

Diversification Opportunities for Acrivon Therapeutics, and Valneva SE

0.68

Correlation Coefficient

Acrivon Therapeutics,  Valneva SE

Poor diversification

The 3 months correlation between Acrivon and Valneva is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Valneva SE ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valneva SE ADR and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Valneva SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valneva SE ADR has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Valneva SE go up and down completely randomly.

Pair Corralation between Acrivon Therapeutics, and Valneva SE

Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 1.6 times more return on investment than Valneva SE. However, Acrivon Therapeutics, is 1.6 times more volatile than Valneva SE ADR. It trades about -0.07 of its potential returns per unit of risk. Valneva SE ADR is currently generating about -0.36 per unit of risk. If you would invest  949.00  in Acrivon Therapeutics, Common on August 30, 2024 and sell it today you would lose (197.00) from holding Acrivon Therapeutics, Common or give up 20.76% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Acrivon Therapeutics, Common  vs.  Valneva SE ADR

Acrivon Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Valneva SE ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Acrivon Therapeutics, and Valneva SE

The main advantage of trading using opposite Acrivon Therapeutics, and Valneva SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Valneva SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valneva SE will offset losses from the drop in Valneva SE's long position.

The idea behind Acrivon Therapeutics, Common and Valneva SE ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.